Find trials
Search tips

Obtain Fresh Glioblastoma Tissue to Analyze Cell Count and Viability in Developing IGV-001

Overview

About this study

The purpose of this study is to utilize fresh tumor tissue to aid the development of future therapies for brain cancer.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

      •  
  • Provide signed and dated informed consent form.
  • English speaking.
  • Any individual >18 years old,
  • Patients eligible for and undergoing craniotomy for diagnostic and therapeutic purposes.
  • Please note: Patients undergoing craniotomy for presumed diagnosis of Grade IV GBM are eligible.

Exclusion Criteria:

  • N/A.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/14/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Alfredo Quinones-Hinojosa, M.D.

Closed for enrollment

Contact information:

Alfredo Quinones-Hinojosa M.D.

(904) 956-3435

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20534514

Mayo Clinic Footer